loadpatents
name:-0.037035942077637
name:-0.010527849197388
name:-0.00051498413085938
Curd; John G. Patent Filings

Curd; John G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Curd; John G..The latest application filed is for "treatment of autoimmune diseases".

Company Profile
0.10.31
  • Curd; John G. - Hillsborough CA
  • Curd; John G. - Burlingame CA
  • Curd; John G. - Burlinggame CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Of Autoimmune Diseases
App 20180264107 - Curd; John G. ;   et al.
2018-09-20
Treatment of pemphigus
Grant 9,993,550 - Curd , et al. June 12, 2
2018-06-12
Treatment Of Pemphigus
App 20160175435 - Curd; John G. ;   et al.
2016-06-23
Administration Of Glufosfamide For The Treatment Of Cancer
App 20160143929 - Curd; John G.
2016-05-26
Treatment Of Cancer Using Hypoxia Activated Prodrugs
App 20150258125 - Curd; John G. ;   et al.
2015-09-17
Treatment of cancer using hypoxia activated prodrugs
Grant 8,946,275 - Curd , et al. February 3, 2
2015-02-03
Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs
Grant 8,883,775 - Curd , et al. November 11, 2
2014-11-11
Treatment Of Multiple Sclerosis
App 20140134164 - Curd; John G. ;   et al.
2014-05-15
Treatment Of Pemphigus
App 20130330332 - Curd; John G. ;   et al.
2013-12-12
Treatment Of Multiple Sclerosis
App 20130273042 - Curd; John G. ;   et al.
2013-10-17
Treatment of vasculitis
Grant 8,545,843 - Curd , et al. October 1, 2
2013-10-01
Treatment of Cancer Using Hypoxia Activated Prodrugs
App 20130202716 - Curd; John G. ;   et al.
2013-08-08
Treatment Of Multiple Sclerosis
App 20130084289 - Curd; John G. ;   et al.
2013-04-04
Treatment Of Multiple Sclerosis
App 20120201818 - Curd; John G. ;   et al.
2012-08-09
Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
Grant 8,206,711 - White , et al. June 26, 2
2012-06-26
Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs
App 20120107230 - CURD; JOHN G. ;   et al.
2012-05-03
Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs
Grant 8,048,872 - Curd , et al. November 1, 2
2011-11-01
Administration of Glufosfamide For The Treatment of Cancer
App 20110207680 - Curd; John G.
2011-08-25
Treatment of Autoimmune Diseases
App 20110008338 - Curd; John G. ;   et al.
2011-01-13
Treatment of Autoimmune Diseases
App 20110008337 - Curd; John G. ;   et al.
2011-01-13
Treatment of Autoimmune Diseases
App 20110008336 - Curd; John G. ;   et al.
2011-01-13
Treatment of Autoimmune Diseases
App 20110008250 - Curd; John G. ;   et al.
2011-01-13
Treatment of autoimmune diseases
Grant 7,820,161 - Curd , et al. October 26, 2
2010-10-26
Treatment of Chronic Lymphocytic Leukemia using Anti-CD20 Antibodies
App 20100080769 - Grillo-Lopez; Antonio J. ;   et al.
2010-04-01
Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
Grant 7,682,612 - White , et al. March 23, 2
2010-03-23
Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds
App 20090163453 - Curd; John G. ;   et al.
2009-06-25
Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
App 20090069276 - Curd; John G. ;   et al.
2009-03-12
1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof
App 20080305082 - Curd; John G. ;   et al.
2008-12-11
Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs
App 20080305075 - Curd; John G. ;   et al.
2008-12-11
Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
App 20080069814 - CURD; John G. ;   et al.
2008-03-20
Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
App 20070275934 - Curd; John G.
2007-11-29
Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof
App 20070037779 - Curd; John G. ;   et al.
2007-02-15
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
App 20070027120 - Whitehouse; Martha J. ;   et al.
2007-02-01
Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments
App 20060177374 - Curd; John G. ;   et al.
2006-08-10
Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents
App 20060178351 - Curd; John G. ;   et al.
2006-08-10
Treatment of lung cancer with active vitamin D compounds in combination with other treatments
App 20060172014 - Curd; John G. ;   et al.
2006-08-03
1,4-bis-N-oxide azaanthracenediones and the use thereof
App 20050222190 - Curd, John G. ;   et al.
2005-10-06
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
App 20050101576 - Whitehouse, Martha J. ;   et al.
2005-05-12
Treatment of liver disease with active vitamin D compounds
App 20050009793 - Curd, John G.
2005-01-13
Company Registrations
SEC0001360787Curd John G

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed